16th Jan 2024 11:36
Ondine Biomedical Inc - Vancouver-based life sciences company - Appoints Joseph Errico as chief financial officer, though doesn't provide start date. Says Errico has successfully founded, sold, or taken public several medical device and pharmaceutical companies, including ElectroCore, Fastenetix, K2 Medical Systems, AD4-Pharma, E2, and SpineCore.
Chief Executive Officer Carolyn Cross says: "We are delighted that JP has agreed to join Ondine at this exciting time. His experience in finance, capital markets and developing medtech companies will be invaluable as we move forward with our international expansion and achieving FDA approval in conjunction with our partner HCA Healthcare."
Current stock price: 9.00 pence, up 2.9%
12-month change: down 45%
By Holly Beveridge, Alliance News reporter
Comments and questions to [email protected]
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Related Shares:
Ondine Biomed